Preprandial vs. postprandial insulin lispro - A comparative crossover trial in patients with Type 1 diabetes

Diabetic Medicine

Volumn 21, Issue 3, 2004, Pages 279-284

  Schernthaner, G ^a   Wein, W ^b   Shnawa, N ^a   Bates, P C ^b   Birkett, M A ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Insulin lispro; Intensive insulin therapy; Postprandial; Type 1 diabetes

Indexed keywords

FRUCTOSAMINE; HEMOGLOBIN A1C; INSULIN LISPRO;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG THERAPY; EATING; FEMALE; FOOD INTAKE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MALE; PHARYNGITIS; POSTPRANDIAL STATE; PREPRANDIAL STATE; RHINITIS;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; EATING; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INJECTIONS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 1542344891     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01132.x     Document Type: Article

References (16)

1. Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 1999; 42: 1151-1167.
2. Anderson JH, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L et al. and the Multicenter Insulin Lispro Study Group. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 1997; 46: 265-270.
3. Anderson JH, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 1249-1255.
4. Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA. Postprandial insulin lispro: a new therapeutic option for type 1 diabetic patients. Diabetes Care 1998; 21: 570-573.
5. Stiller R, Gudat U, Pfutzner A, Trautmann M, Haslbeck M. Post-prandial treatment with insulin lispro. Diabetes Metab 1997; 23: 232-233.
6. American Diabetes Association. Insulin administration. Diabetes Care 1995; 18: 29-32.
7. Valle D, Santoro D, Bates P, Scarpa L. The Italian Multicentre Lispro Study Group. Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with type 1 diabetes. Diabetes Nutr Metab 2001; 14: 126-132.
8. Kotsanos JG, Vignati L, Huster W, Andrejasich C, Boggs MB, Jacobson AM et al. Health-related quality-of-life results from multinational and clinical trials of insulin lispro. Diabetes Care 1997; 20: 948-958.
9. Rami B, Schober E. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes. Eur J Pediatr 1997; 156: 838-840.
10. Rutledge KS, Chase HP, Klingensmith GJ, Walravens PA, Slover RH, Garg SK. Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics 1997; 100: 968-972.
11. Strachan MW, Frier BM. Optimal time of administration of insulin lispro: importance of meal composition. Diabetes Care 1998; 21: 26-31.
12. Burge MR, Castillo KR, Schade DS. Meal composition is a determinant of lispro-induced hypoglycaemia in IDDM. Diabetes Care 1997; 20: 152-155.
13. Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24: 1264-1269.
14. 1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Diabetes Care 1999; 22: 795-800.
15. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995; 44: 968-983.
16. Gale EAM. A randomized, controlled trial comparing insulin lispro with soluble insulin in patients with type 1 diabetes on intensified insulin therapy. Diabet Med 2000; 17: 209-214.